SAT1 is overexpressed in intestinal cancer, breast cancer and melanomas, compared to control39, while PLSCR1 has been previously linked with proliferation arrest of leukaemia cells and granulocyte-like differentiation, as well as causing downregulation of MYC, which is also implicated in the latter process (as discussed below)40. Here, PLSCR1 is linked to melanoma.